You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
Attention over time
Attention Score history
Activity
X Demographics
Mendeley demographics
Login to view Mendeley reader trends over time.
Attention Score in Context
| Title |
Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke–Enhanced Regimen Stroke Trial
|
|---|---|
| Published in |
Stroke, July 2013
|
| DOI | 10.1161/strokeaha.113.001059 |
| Pubmed ID | |
| Authors |
Arthur M. Pancioli, Opeolu Adeoye, Pamela A. Schmit, Jane Khoury, Steven R. Levine, Thomas A. Tomsick, Heidi Sucharew, Claudette E. Brooks, Todd J. Crocco, Laurie Gutmann, Thomas M. Hemmen, Scott E. Kasner, Dawn Kleindorfer, William A. Knight, Sharyl Martini, James S. McKinney, William J. Meurer, Brett C. Meyer, Alexander Schneider, Phillip A. Scott, Sidney Starkman, Steven Warach, Joseph P. Broderick, Arthur M. Pancioli, Opeolu Adeoye, Joseph Broderick, Pamela A. Schmit, Jane Khoury, Heidi Sucharew, Scott Janis, Thomas Tomsick, Claudette E. Brooks, Todd Crocco, Thomas Hemmen, Scott E. Kasner, James S. McKinney, William J. Meurer, Alex Schneider, Sidney Starkman, Steven Warach, Steven Levine, Claudia Moy, K. Michael Welch, Gretchen Tietjen, William R. Clarke, Jordan Bonomo, Erin McDonough, Simona Ferioli, Felipe de los Rios De la Rosa, Sharyl Martini, Daniel Woo, Rachel Garvin, Dawn Kleindorfer, Pooja Khatri, Anna Gensic, Matthew Flaherty, Daniel Kanter, Brett Kissela, Brian Stettler, Jason Mackey, Rhonda Cadena, Shannon Kohake, Laura Heitsch, Samir Belagaje, Achala Vagal, John Hallenbeck, Richard Benson, Amie Hsia, Rakesh Jaitly, Lawrence Latour, John Lynch, Jose Merino, Ravi Menon, Jason Freeman, Alejandro Magadan, Nandakumar Magaraja, Jennifer Jothen, Bonanle Famakin, Shlee Song, Alex Katcheves, Zurab Nadareishvili, Carsen Ritter, William Barsan, Devin Brown, Lewis Morgenstern, Robert Silbergleit, Venkatakrishna Rajajee, Lesli Rusche-Skolarus, Jim Burke, Jeffrey Fletcher, Eric Adelman, Michael Wang, Darin Zahuranec, Brett Cucchiara, Steven Messe, Christina Wilson, Koto Ishida, Michael Mullen, Jonathan Raser, Swaroop Pawar, David Rose, Neelofer Shafi, Igor Rybinnik, Michael McGavery, Lauren Beslow, Lauren Sansing, Latisha Ali, Hermelinda Abcede, Peter Adamczyk, William Buxton, Michael Froehler, Doojin Kim, David Liebeskind, Bruce Ovbiagele, Verna Porter, Venkatakrishna Rajajee, Neal Rao, Radoslav Raychev, Sarah Song, Jeffrey Saver, Matthew Tenser, Shamsha Velani, Anil Yallapragada, Brett Meyer, Any Guzik, Kiet Loc, Dawn Meyer, Gilda Tafreshi, Jessica Choe, Ajeet Sodhi, Patrick Delaney, Sean Evans, Omar A. Ghausi, Nhu Bruce, Will Neil, Brank Huisa, Andrew Stemer, Reid Taylor, Jeanette Larson, Seth Larson, Rodney Leacock, Subasisni Dash, Robert Eisenstein, Raffi Kapitanyan, Ugo Paolucci, Chirag Shah, Win Toe, John Brick, Owen Lander, Hollynn Larrabee, Laurie Gutmann, Joseph Minardi, Allison Tadros, Roger Tillotson, Charles Whiteman, Debra Paulson, Rosanna Sikora, Christopher Cummings, John Foster, Janice Carrozzella, Traci Doellman, Irene Ewing, Jamey Frasure, Emily Goodall, Pamela Kimmel, Judith Spilker, Robert Tamer, Peggy Waymeyer, Joyce Zeigler, Lisa Davis, Saman Farsad, Teresa Morella, Allison Kade, Shirley Frederiksen, Mary Liz, Jean Luciano, Judy Guzy, Ileana Grunberg, Teresa Rzesiewicz, Karen Rapp, Tracy Nanney, Leslie Shell, Margaret Perkins, Cindy Benton, Robin Jones, Lynne Hampton, Claudine Cuento, Rachel Alosky, Stephanie Shepard, Michelle Moccio, Catherine Albrecht, Yaritza Rosario, Deborah Caputo, Stephen Davis, Patricia Altemus, Martha Power, Reyna VanGilder, Jay Sherman, Taura Barr |
| Abstract |
In a previous study, 0.3 and 0.45 mg/kg of intravenous recombinant tissue plasminogen activator (rt-PA) were safe when combined with eptifibatide 75 mcg/kg bolus and a 2-hour infusion (0.75 mcg/kg per minute). The Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke-Enhanced Regimen (CLEAR-ER) trial sought to determine the safety of a higher-dose regimen and to establish evidence for a phase III trial. |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 50% |
| Members of the public | 1 | 50% |
Mendeley demographics
The data shown below were compiled from readership statistics for 79 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 1% |
| Unknown | 78 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 11 | 14% |
| Student > Doctoral Student | 9 | 11% |
| Student > Bachelor | 9 | 11% |
| Other | 5 | 6% |
| Student > Ph. D. Student | 5 | 6% |
| Other | 19 | 24% |
| Unknown | 21 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 33 | 42% |
| Biochemistry, Genetics and Molecular Biology | 6 | 8% |
| Agricultural and Biological Sciences | 5 | 6% |
| Nursing and Health Professions | 2 | 3% |
| Chemical Engineering | 1 | 1% |
| Other | 6 | 8% |
| Unknown | 26 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 53. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 September 2013.
All research outputs
#793,885
of 25,374,917 outputs
Outputs from Stroke
#613
of 12,372 outputs
Outputs of similar age
#6,337
of 209,986 outputs
Outputs of similar age from Stroke
#7
of 206 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,372 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.6. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 209,986 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 206 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.